These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 526752)

  • 1. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR; Nahorski SR
    Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752
    [No Abstract]   [Full Text] [Related]  

  • 2. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR; Morris H; Nahorski SR
    Br J Pharmacol; 1979 May; 66(1):136P. PubMed ID: 454928
    [No Abstract]   [Full Text] [Related]  

  • 3. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 4. [3H]spiperone binding sites in rat primary glial cultures, C6 glioma, and B104 neuroblastoma.
    Severson JA; de Vellis JS; Finch CE
    J Neurosci Res; 1983; 9(1):21-6. PubMed ID: 6834436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
    Noguchi-kuno SA; Nakata C; Nishitani H
    Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
    [No Abstract]   [Full Text] [Related]  

  • 10. Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.
    Howlett DR; Morris H; Nahorski SR
    Mol Pharmacol; 1979 May; 15(3):506-14. PubMed ID: 492143
    [No Abstract]   [Full Text] [Related]  

  • 11. Postsynaptic location of acrylamide-induced modulation of striatal 3H-spiroperidol binding.
    Hong JS; Tilson HA; Agrawal AK; Karoum F; Bondy SC
    Neurotoxicology; 1982 Jul; 3(1):108-12. PubMed ID: 6890181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two binding sites for 3H-spiroperidol on rat striatal membranes.
    Briley M; Langer SZ
    Eur J Pharmacol; 1978 Aug; 50(3):283-4. PubMed ID: 28956
    [No Abstract]   [Full Text] [Related]  

  • 13. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
    Agnati LF; Fuxe K; Battistini N; Benfenati F
    Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074
    [No Abstract]   [Full Text] [Related]  

  • 14. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum.
    Hennies HH; Hess V; Flohé L
    Arzneimittelforschung; 1984; 34(11):1481-4. PubMed ID: 6543122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC; Carino MA; Horita A
    Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
    [No Abstract]   [Full Text] [Related]  

  • 17. Lisuride inhibits 3H-spiroperidol binding to membranes isolated from striatum.
    Fujita N; Saito K; Yonehara N; Yoshida H
    Neuropharmacology; 1978 Dec; 17(12):1089-91. PubMed ID: 745698
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites.
    Fuxe K; Agnati LF; Benfenati F; Cimmino M; Algeri S; Hökfelt T; Mutt V
    Acta Physiol Scand; 1981 Dec; 113(4):567-9. PubMed ID: 6291324
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
    Owen F; Cross AJ; Waddington JL; Poulter M; Gamble SJ; Crow TJ
    Life Sci; 1980 Jan; 26(1):55-9. PubMed ID: 7189005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.